clinicaltrials.gov
ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS 피드
ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days의 최신 업데이트를 올라오는 즉시 받아보세요.
최신 게시물
평소 읽는 곳에서 ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days 받아보기
ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days 팔로워가 함께 팔로우하는 피드
-
Chugai Pharmaceutical: News Releases chugai-pharm.co.jp
-
Regeneron Pharmaceuticals Inc. News Releases investor.regeneron.com
-
What's new ema.europa.eu
-
Roche Media News roche.com
-
질문
ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days의 RSS 피드 URL은 무엇인가요?
피드 주소는 https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=secukinumab&recrs=abdef&type=Intr&phase=0124&fund=2&count=10000입니다. RSS 리더에 붙여넣거나 지금 팔로우를 클릭하여 Feeder에서 읽어보세요.
ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days의 게시 빈도는 어떻게 되나요?
ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days 게시 빈도: 일주일에 1회 미만. 마지막 게시물은 1일 전에 게시되었습니다.
ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS 피드가 정상적으로 작동하나요?
예. Feeder가 대략 1시간 전에 확인했으며 피드가 정상적으로 응답했습니다.
ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days에서는 어떤 주제를 다루나요?
Feeder에서 Health 주제로 분류됩니다.
Feeder에서 ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days을 어떻게 팔로우하나요?
지금 팔로우를 클릭하고, 아직 계정이 없다면 가입하세요. Feeder의 무료 요금제에서는 웹, iPhone, Android에서 최대 200개의 피드를 이용할 수 있습니다. 신용카드는 필요하지 않습니다.
Feeder에서 ClinicalTrials.gov: secukinumab | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days 팔로우하기
Feeder의 무료 요금제에서는 웹, iPhone, Android에서 최대 200개의 피드를 이용할 수 있습니다. 신용카드는 필요하지 않습니다.